Gladstone Institutional Advisory’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$240K Sell
1,336
-1,111
-45% -$190K 0.01% 746
2025
Q4
$346K Sell
2,447
-2,026
-45% -$230K 0.01% 597
2025
Q3
$363K Buy
+4,473
New +$345K 0.01% 594
2023
Q2
Sell
-1,081
Closed -$239K 635
2023
Q1
$239K Sell
1,081
-27,383
-96% -$6.75M 0.02% 579
2022
Q4
$6.17M Buy
28,464
+27,405
+2,588% +$7.3M 0.44% 53
2022
Q3
$280K Buy
+1,059
New +$269K 0.02% 513

Other funds holding ALB

Gladstone Institutional Advisory's ALB Position: Q1 2026 in Review

Gladstone Institutional Advisory reduced its Albemarle (ALB) stake by 45% in Q1 2026, selling an estimated $190K and leaving 1,336 shares worth $240K. The position accounts for 0.01% of the portfolio, ranked #746.

Gladstone Institutional Advisory first reported a position in ALB in Q3 2022 and has held it in 6 quarters since. The position peaked at $6.17M in Q4 2022. 982 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

  • Gladstone Institutional Advisory held 1,336 shares of Albemarle worth $240K as of Q1 2026.
  • Gladstone Institutional Advisory sold 1,111 Albemarle shares in Q1 2026, an estimated $190K.
  • Albemarle made up 0.01% of Gladstone Institutional Advisory's portfolio in Q1 2026, its #746 holding.
  • Gladstone Institutional Advisory first reported a position in Albemarle in Q3 2022 and has held it in 6 quarters since.
  • Gladstone Institutional Advisory's Albemarle position peaked at $6.17M in Q4 2022.
  • 982 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q1 2026, filed 14 May 2026.